Franklin Street Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,090
Closed -$243K 174
2016
Q4
$243K Hold
10,090
0.04% 155
2016
Q3
$280K Hold
10,090
0.05% 157
2016
Q2
$246K Sell
10,090
-2,422
-19% -$68.7K 0.05% 167
2016
Q1
$420K Sell
12,512
-1,614
-11% -$50.8K 0.08% 147
2015
Q4
$422K Buy
14,126
+1,312
+10% +$44.2K 0.08% 152
2015
Q3
$404K Sell
12,814
-580
-4% -$28.3K 0.08% 151
2015
Q2
$648K Sell
13,394
-78
-0.6% -$3.29K 0.12% 135
2015
Q1
$584K Sell
13,472
-4,002
-23% -$144K 0.11% 132
2014
Q4
$460K Sell
17,474
-10,568
-38% -$232K 0.09% 140
2014
Q3
$498K Buy
28,042
+17,579
+168% +$359K 0.09% 162
2014
Q2
$251K Hold
10,463
0.05% 209
2014
Q1
$263K Hold
10,463
0.05% 202
2013
Q4
$238K Buy
+10,463
New +$211K 0.05% 212

Other funds holding PGEN

Franklin Street Advisors's PGEN Position: Q1 2017 in Review

Franklin Street Advisors sold out of Precigen (PGEN) in Q1 2017, closing a stake of 10,090 shares — an estimated $243K sold.

Franklin Street Advisors first reported a position in PGEN in Q4 2013 and held it in 13 quarters. The position peaked at $648K in Q2 2015. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2017.

  • Franklin Street Advisors reported no remaining Precigen position as of Q1 2017 after selling out during the quarter.
  • Franklin Street Advisors sold 10,090 Precigen shares in Q1 2017, an estimated $243K.
  • Franklin Street Advisors first reported a position in Precigen in Q4 2013 and held it in 13 quarters.
  • Franklin Street Advisors's Precigen position peaked at $648K in Q2 2015.
  • 154 funds tracked by Wall St. Rank held Precigen as of Q1 2017.

Based on Franklin Street Advisors's 13F filing for Q1 2017, filed 4 Apr 2017.